Dr. Deborah Sherman, MD
NPI: 1275674590
Total Payments
$3.4M
2024 Payments
$398,479
Companies
9
Transactions
2,552
Medicare Patients
3,423
Medicare Billing
$440,685
Payment Breakdown by Category
Other$2.4M (68.8%)
Consulting$633,027 (18.5%)
Travel$242,640 (7.1%)
Research$139,435 (4.1%)
Food & Beverage$47,978 (1.4%)
Education$3,069 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.4M | 470 | 68.8% |
| Consulting Fee | $633,027 | 132 | 18.5% |
| Travel and Lodging | $242,640 | 789 | 7.1% |
| Unspecified | $139,435 | 9 | 4.1% |
| Food and Beverage | $47,978 | 1,005 | 1.4% |
| Education | $3,069 | 147 | 0.1% |
Payments by Type
General
$3.3M
2,543 transactions
Research
$139,435
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $2.3M | 1,822 | $0 (2023) |
| ABBVIE INC. | $1.1M | 615 | $0 (2024) |
| Galderma Laboratories, L.P. | $17,714 | 64 | $0 (2024) |
| Merz Pharmaceuticals GmbH | $1,708 | 20 | $0 (2017) |
| MERZ NORTH AMERICA, INC. | $1,318 | 13 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $557.48 | 15 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $24.07 | 1 | $0 (2021) |
| Stryker Corporation | $15.46 | 1 | $0 (2021) |
| Mallinckrodt LLC | $10.41 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $398,479 | 322 | ABBVIE INC. ($397,191) |
| 2023 | $667,897 | 299 | AbbVie Inc. ($667,351) |
| 2022 | $634,005 | 426 | Allergan, Inc. ($633,522) |
| 2021 | $401,461 | 344 | Allergan, Inc. ($401,288) |
| 2020 | $191,253 | 154 | Allergan, Inc. ($191,201) |
| 2019 | $445,596 | 446 | Allergan Inc. ($436,364) |
| 2018 | $287,063 | 203 | Allergan Inc. ($286,759) |
| 2017 | $395,713 | 358 | Allergan Inc. ($385,804) |
All Payment Transactions
2,552 individual payment records from CMS Open Payments — Page 3 of 103
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $27.81 | General |
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $127.93 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,850.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/22/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| 10/22/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| 10/22/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15,000.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/16/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $60.33 | General |
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/04/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $20.00 | General |
| 10/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.83 | General |
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $435.30 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $328.95 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $139.23 | General |
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $125.05 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $57.82 | General |
| 10/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $52.83 | General |
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.77 | General |
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.81 | General |
| 10/02/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $139.23 | General |
| 10/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: FACIAL AESTHETICS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines | AbbVie Inc. | $133,706 | 4 |
| QUALITATIVE DEVELOPMENT OF PATIENT-REPORTED OUTCOME MEASURES IN THE JOWL AREA | Allergan, Inc. | $4,725 | 2 |
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $1,004 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 663 | 736 | $425,202 | $95,275 |
| 2022 | 15 | 949 | 1,050 | $550,157 | $126,488 |
| 2021 | 15 | 934 | 1,068 | $423,037 | $111,390 |
| 2020 | 13 | 877 | 1,014 | $449,190 | $107,532 |
Total Patients
3,423
Total Services
3,868
Medicare Billing
$440,685
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $2,013 | $947.07 | 47.0% |
| 92081 | Exam of visual field with limited testing | Facility | 2022 | 76 | 76 | $4,940 | $780.01 | 15.8% |
| 92081 | Exam of visual field with limited testing | Office | 2022 | 13 | 13 | $910.00 | $260.40 | 28.6% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2021 | 41 | 41 | $114,800 | $24,012 | 20.9% |
| 64612 | Injection of chemical for destruction of nerve muscles on one side of face | Facility | 2021 | 47 | 144 | $52,460 | $15,679 | 29.9% |
| 67950 | Enlargement of eyelid margin | Facility | 2021 | 46 | 47 | $67,500 | $14,558 | 21.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 100 | 100 | $24,900 | $11,514 | 46.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 122 | 122 | $20,008 | $9,365 | 46.8% |
| 67810 | Biopsy of eyelid | Office | 2021 | 61 | 71 | $22,800 | $8,750 | 38.4% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2021 | 12 | 12 | $33,000 | $7,775 | 23.6% |
| 68840 | Probing of nasal-tear duct | Office | 2021 | 34 | 36 | $20,100 | $4,775 | 23.8% |
| 92285 | Photography of content of eyes | Office | 2021 | 277 | 291 | $21,825 | $4,421 | 20.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 43 | $5,375 | $2,783 | 51.8% |
| 67914 | Suture repair of a turning-outward defect of upper or lower eyelid | Facility | 2021 | 15 | 15 | $16,800 | $2,615 | 15.6% |
| 68815 | Probing of nasal-tear duct with insertion of tube or stent | Facility | 2021 | 12 | 17 | $11,400 | $1,685 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 18 | $3,294 | $1,673 | 50.8% |
| 92081 | Measurement of field of vision during daylight conditions, limited examination | Facility | 2021 | 85 | 85 | $5,525 | $1,005 | 18.2% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 26 | 26 | $3,250 | $781.81 | 24.1% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2020 | 53 | 53 | $148,400 | $32,600 | 22.0% |
| 64612 | Injection of chemical for destruction of nerve muscles on one side of face | Facility | 2020 | 61 | 161 | $58,480 | $15,498 | 26.5% |
| 67950 | Enlargement of eyelid margin | Facility | 2020 | 44 | 46 | $57,600 | $14,405 | 25.0% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2020 | 226 | 226 | $28,250 | $12,344 | 43.7% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2020 | 15 | 15 | $38,500 | $9,578 | 24.9% |
| 67810 | Biopsy of eyelid | Office | 2020 | 36 | 45 | $14,100 | $5,198 | 36.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 55 | 64 | $6,400 | $3,924 | 61.3% |
About Dr. Deborah Sherman, MD
Dr. Deborah Sherman, MD is a Ophthalmic Plastic and Reconstructive Surgery healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275674590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Sherman, MD has received a total of $3.4M in payments from pharmaceutical and medical device companies, with $398,479 received in 2024. These payments were reported across 2,552 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.4M).
As a Medicare-enrolled provider, Sherman has provided services to 3,423 Medicare beneficiaries, totaling 3,868 services with total Medicare billing of $440,685. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmic Plastic and Reconstructive Surgery
- Other Specialties Plastic and Reconstructive Surgery, Ophthalmology
- Location Nashville, TN
- Active Since 02/09/2007
- Last Updated 06/09/2025
- Taxonomy Code 207WX0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275674590
Products in Payments
- BOTOX (Biological) $1.3M
- KYBELLA (Biological) $137,552
- BOTOX COSMETIC (Biological) $69,362
- Xeomin (Biological) $2,096
- DAXXIFY (Drug) $557.48
- XEOMIN (Biological) $220.26
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $140.68
- ZYLET (Drug) $24.07
- STRYKER (Device) $15.46
- VUITY (Drug) $15.45
- ACTHAR (Biological) $10.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.